2m 2m 2m 2m 2m 2m 2m
LEXEO (LXEO)
NASDAQ
$4.25-$0.005 (-0.12%)
Price as of Sep 11, 2026 7:30 PM EDT- $348.7MMarket Cap
- -17.95%1-Year Change
- BiotechnologyIndustry
LEXEO (LXEO)
$4.25-$0.005 (-0.12%)
LXEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.25 | ||
Change | -$0.11 (-2.52%) | ||
Open | $4.43 | ||
High | $4.47 | ||
Low | $4.21 | ||
Previous Close | $4.36 | ||
Volume | 1,490,757 | ||
30-Day Average Volume | 727,828 | ||
1-Week Change | -13.09% | ||
1-Month Change | -11.09% | ||
1-Year Change | -17.95% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 82.0M | ||
Total Assets | $254.9M | ||
Market Cap | $348.7M | ||
Enterprise Value | $255.9M | ||
Period: QTR TTM FY | |||
Revenue | -$156,000.00 | ||
Net Income | -$25.9M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$25.9M | ||
EBITDA | -$25.8M | ||
Net Working Capital | $202.2M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | -1,640 | ||
P/B | 1 | ||
P/E | -14 | ||
PEG | 1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue